TrialThe New England journal of medicine2013
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.
John C Byrd et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,118 papers cite itlatest 60 shown
this paperpooled ittrialcites it